Hemab Therapeutics Holdings, Inc. (COAG)
41.45
+1.03
(+2.55%)
USD |
NASDAQ |
Oct 30, 16:00
41.45
0.00 (0.00%)
After-Hours: 20:00
Hemab Therapeutics Holdings EPS Diluted (Quarterly) : -0.5171 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.5171 |
| March 31, 2026 | -0.4858 |
| Date | Value |
|---|---|
| June 30, 2025 | -0.2614 |
| March 31, 2025 | -0.3277 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
| Anixa Biosciences, Inc. | -0.0762 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -24.15M |
| Total Expenses (Quarterly) | 24.15M |
| Enterprise Value | 1.480B |
| Earnings Yield | -3.84% |
| Normalized Earnings Yield | -3.840 |